ICD-10-PCS Billable Code

DP062ZZ

Beam Radiation Humerus to None with None, Photons >10 MeV Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionD Radiation Therapy
Body SystemP Musculoskeletal System
Operation0 Beam Radiation
Body Part6 Humerus
Approach2 Photons >10 MeV
DeviceZ None
QualifierZ None

Procedure Overview

Beam radiation to the musculoskeletal system directs external radiation, generated by a linear accelerator outside the body, at bone, cartilage, muscle, or connective tissue affected by a primary tumor such as osteosarcoma or soft tissue sarcoma, or by metastatic disease that has spread to bone from another cancer. Treatment is spread across multiple sessions - often several weeks' worth - to allow healthy tissue time to recover between doses while the tumor accumulates cell-killing damage.

For many patients, especially those with bone metastases, this treatment is aimed less at cure and more at controlling pain and preventing fracture in a weakened bone. For primary bone and soft tissue sarcomas, it is frequently paired with surgery to lower the chance the tumor returns at the original site.

Anatomy & Axis Detail

Humerus

The humerus is the long bone of the upper arm, extending from the shoulder to the elbow, and its proximal and diaphyseal regions are relatively common sites for metastatic deposits from breast, lung, and renal primaries as well as for primary bone tumors in younger patients. External beam radiation here is often used for pain palliation or to consolidate a lesion at risk of pathologic fracture, sometimes following prophylactic fixation with hardware that must be accounted for in dosimetry because metal can perturb the beam. The nerve plexus and vessels running along the arm are close to the bone, so field borders are drawn to limit dose to these structures where possible. Reports should specify whether the proximal, shaft, or distal humerus was treated, since the level affects nearby structures at risk.

Modality Qualifier: Photons >10 MeV

Photons >10 MeV designates the high-energy megavoltage photon beams produced by linear accelerators, used for deep-seated tumors where sufficient skin-sparing and tissue penetration are needed. It sits above the lower-energy photon options in dose distribution and reach, letting treatment planners target structures well below the surface without excessive skin dose. It differs from Electrons, which deposit energy more superficially and are chosen for shallow lesions instead.

Coding & Documentation

The operative or treatment note needs to specify the exact musculoskeletal structure being treated - a particular long bone, vertebra, joint, or muscle group - since the body part value in this family is granular. The modality qualifier (photon, electron, proton, or neutron beam) should also be documented, as this affects code selection even when the anatomic target and fractionation pattern are otherwise identical.

The most common error is coding to a general or adjacent body part when the tumor sits at a joint or transition zone rather than the shaft of a bone, which changes the correct value. Coders also sometimes miss the modality qualifier entirely when the note only says "radiation therapy" without specifying the beam type used by the treatment plan.

Commonly Confused With

This family is frequently confused with stereotactic body radiation therapy aimed at the same bone or soft tissue target, where the distinguishing factor is fractionation - conventional beam radiation spans many standard-dose sessions, while stereotactic delivery compresses treatment into one to five highly targeted, high-dose sessions. It should also be distinguished from Other Radiation, reserved for techniques like intraoperative delivery during tumor resection surgery.